WallStreetZenWallStreetZen

NASDAQ: MORF
Morphic Holding Inc Stock

$29.23-3.22 (-9.92%)
Updated May 17, 2024
MORF Price
$29.23
Fair Value Price
$1.09
Market Cap
$1.46B
52 Week Low
$19.35
52 Week High
$63.08
P/E
-8.35x
P/B
2.21x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$161.25M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.03
Operating Cash Flow
-$127M
Beta
1.46
Next Earnings
May 31, 2024
Ex-Dividend
N/A
Next Dividend
N/A

MORF Overview

Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; and preclinical trial to treat idiopathic pulmonary fibrosis and fibrosis diseases. The company is also developing avß6 for the treatment of fibrotic diseases, and avß8 to treat solid tumors, as well as various other products. Morphic Holding, Inc. has a research collaboration with Engitix Ltd for the identification of Morphic integrin technology amenable targets in fibrostenotic IBD; a collaboration agreement with Schrödinger, LLC for integrin targets; and a license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. It also has collaboration agreements with AbbVie Biotechnology Ltd and Janssen Pharmaceuticals, Inc. to discover or develop integrin-based therapeutics. Morphic Holding, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Zen Score

Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MORF scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MORF ($29.23) is overvalued by 2,591.96% relative to our estimate of its Fair Value price of $1.09 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
MORF ($29.23) is not significantly undervalued (2,591.96%) relative to our estimate of its Fair Value price of $1.09 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
MORF is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more MORF due diligence checks available for Premium users.

Be the first to know about important MORF news, forecast changes, insider trades & much more!

MORF News

Valuation

MORF fair value

Fair Value of MORF stock based on Discounted Cash Flow (DCF)
Price
$29.23
Fair Value
$1.09
Overvalued by
2,591.96%
MORF ($29.23) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MORF ($29.23) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MORF is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

MORF price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-8.35x
Industry
8.47x
Market
30.97x

MORF price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.21x
Industry
6.01x
MORF is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MORF's financial health

Profit margin

Revenue
$0.0
Net Income
-$45.3M
Profit Margin
0%
MORF's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$682.8M
Liabilities
$19.2M
Debt to equity
0.03
MORF's short-term assets ($675.94M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MORF's short-term assets ($675.94M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MORF's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MORF's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$46.4M
Investing
$31.4M
Financing
$911.0k
MORF's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

MORF vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
MORF$1.46B-9.92%-8.35x2.21x
TARS$1.44B-0.88%-8.08x5.25x
XNCR$1.42B+2.54%-10.52x2.32x
DAWN$1.41B+0.87%-6.44x4.76x
SYRE$1.52B0.00%-0.81x10.00x

Morphic Holding Stock FAQ

What is Morphic Holding's quote symbol?

(NASDAQ: MORF) Morphic Holding trades on the NASDAQ under the ticker symbol MORF. Morphic Holding stock quotes can also be displayed as NASDAQ: MORF.

If you're new to stock investing, here's how to buy Morphic Holding stock.

What is the 52 week high and low for Morphic Holding (NASDAQ: MORF)?

(NASDAQ: MORF) Morphic Holding's 52-week high was $63.08, and its 52-week low was $19.35. It is currently -53.66% from its 52-week high and 51.1% from its 52-week low.

How much is Morphic Holding stock worth today?

(NASDAQ: MORF) Morphic Holding currently has 50,093,588 outstanding shares. With Morphic Holding stock trading at $29.23 per share, the total value of Morphic Holding stock (market capitalization) is $1.46B.

Morphic Holding stock was originally listed at a price of $18.00 in Jun 27, 2019. If you had invested in Morphic Holding stock at $18.00, your return over the last 4 years would have been 62.39%, for an annualized return of 12.89% (not including any dividends or dividend reinvestments).

How much is Morphic Holding's stock price per share?

(NASDAQ: MORF) Morphic Holding stock price per share is $29.23 today (as of May 17, 2024).

What is Morphic Holding's Market Cap?

(NASDAQ: MORF) Morphic Holding's market cap is $1.46B, as of May 18, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Morphic Holding's market cap is calculated by multiplying MORF's current stock price of $29.23 by MORF's total outstanding shares of 50,093,588.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.